Effects of 5-mg dose of olanzapine for breakthrough nausea and vomiting in patients receiving carboplatin-based chemotherapy: a prospective trial.
Ann Palliat Med
; 10(3): 2699-2708, 2021 Mar.
Article
in En
| MEDLINE
| ID: mdl-33615803
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiemetics
/
Antineoplastic Agents
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
Ann Palliat Med
Year:
2021
Document type:
Article
Affiliation country:
Japón
Country of publication:
China